Lund University Researchers Transform Glial Cells into Neurons

A team of researchers at Lund University has made significant strides in brain repair by successfully transforming human glial cells into parvalbumin (PV) interneurons. This breakthrough, detailed in their study published in Science Advances, offers new hope for addressing cognitive and behavioral disorders linked to the malfunction of these crucial brain cells.

PV interneurons play a vital role in regulating brain activity, maintaining the delicate balance between excitation and inhibition within neural circuits. When these cells are impaired, as seen in conditions like schizophrenia and epilepsy, it can lead to instability in brain function. The challenge has been to generate PV interneurons in vitro, a task that has proven difficult for researchers.

In their innovative approach, the Lund team described a method that allows for the direct reprogramming of human glial progenitor cells (hGPCs) into PV interneurons without the intermediary step of becoming stem cells. “In our study, we have for the first time succeeded in reprogramming human glial cells into parvalbumin neurons that resemble those that naturally exist in the brain,” stated Daniella Rylander Ottosson, PhD, senior author and researcher in regenerative neurophysiology at the university.

The researchers utilized a defined set of five transcription factors—Ascl1, DLX5, LHX6, Sox2, and FOXG1—to facilitate the transformation. Remarkably, this process was completed within weeks, significantly faster than traditional stem cell differentiation methods. The reprogrammed glial cells exhibited neuronal morphology, expressed GABAergic markers, and developed the electrophysiological properties typical of inhibitory interneurons.

In addition to the transformation, single-nucleus RNA sequencing revealed that the reprogrammed cells underwent a rapid transition through distinct developmental stages. Notably, a robust population of PV-enriched cells emerged, displaying molecular characteristics of chandelier cells, which are a specialized type of PV interneuron known for their role in modulating cortical circuits.

The identification of a specific lineage pathway leading to PV fate marks a significant advancement in the field. The study unveiled dynamic gene programs that appear essential for establishing the chandelier-cell phenotype, addressing a long-standing issue in efficiently and reliably generating subtype-specific PV interneurons.

Given that glial cells are abundant and widely distributed throughout the brain, this direct reprogramming method presents a promising avenue for repairing inhibitory circuits that are compromised in various neurological and psychiatric disorders. Despite the challenges of transferring glial reprogramming to human systems—mainly due to the late development of hGPCs—the researchers successfully navigated this barrier by employing a stem-cell-derived hGPC protocol that produces oligodendrocyte precursor-like cells.

The discovery of previously unidentified PV-fate genes may provide insights for future refinements in reprogramming strategies. The ability to generate mature human PV interneurons quickly and reliably could become a foundational element in developing therapies aimed at repairing neural circuits affected by disease.

This pioneering research not only enhances our understanding of PV interneuron development but also opens the door to potential therapeutic applications in treating brain disorders, marking a significant milestone in the field of regenerative neurophysiology.